Lonza Capsules & Health Ingredients - Capsules, Food Additives and Ingredients | Fi South America 2025
Exhibiting at Fi South America 2025
São Paulo
26 Aug - 28 Aug, 2025
Product Offerings
Product Categories:
Capsules, Food Additives and Ingredients, Functional and Nutraceutical Foods, Drug Delivery Devices, Pharmaceutical Products, Packaging, Consulting and Professional Services
Products:
Vcaps® Plus Capsules, Capsugel® Zephyr™, UC-II® Undenatured Type II Collagen, Super CitriMax® 60% HCA, Encapsulation Equipment, VCAPS® Enteric Capsules, ResistAid® Arabinogalactan, Sprinkle Capsules, Hard Capsules, Specialty Health Ingredients, Dosage Form Solutions, L-OptiZinc® Zinc Mono-L-Methionine, Carnipure® L-Carnitine, Press-Fit® Gelcaps
Product Gallery:
UC-II™️
ResistAid™
VCAPS
PLANTCAPS
Product Categories
Capsules
Food Additives and Ingredients
Functional and Nutraceutical Foods
Drug Delivery Devices
Pharmaceutical Products
Packaging
Consulting and Professional Services
Available Products
Vcaps® Plus Capsules
Capsugel® Zephyr™
UC-II® Undenatured Type II Collagen
Super CitriMax® 60% HCA
Encapsulation Equipment
VCAPS® Enteric Capsules
ResistAid® Arabinogalactan
Sprinkle Capsules
Hard Capsules
Specialty Health Ingredients
Dosage Form Solutions
L-OptiZinc® Zinc Mono-L-Methionine
Carnipure® L-Carnitine
Press-Fit® Gelcaps
Lonza Capsules & Health Ingredients (Brazil Office) is the regional subsidiary of Lonza Group AG, a global leader in pharmaceutical, nutraceutical, and biotechnology innovation. Located in Rio de Janeiro, the Brazilian office supports the Latin American market with advanced capsule delivery technologies, clean-label health ingredients, and specialized encapsulation systems under the globally recognized Capsugel® brand.
Lonza, headquartered in Basel, Switzerland, acquired Capsugel in 2017, creating one of the world’s most comprehensive portfolios for oral dosage delivery and ingredient innovation. With operations in over 35 countries and more than 17,000 employees worldwide, Lonza serves customers across pharmaceuticals, consumer health, and nutrition sectors.
In Brazil, Lonza’s Capsules & Health Ingredients division acts as a commercial and technical extension of its global capabilities. The regional team provides support for dietary supplement brands, pharmaceutical developers, and contract manufacturers throughout Latin America, ensuring compliance with ANVISA, Mercosur, and international regulatory frameworks.
Core Business
Lonza Brazil's core business encompasses:
Advanced two-piece hard capsules for pharmaceuticals and nutraceuticals
Custom encapsulation platforms for functional delivery
Local market knowledge combined with global GMP standards
Technical support for formulation challenges and product differentiation
Their “capsule-first” formulation approach offers unmatched flexibility for supplement brands and pharmaceutical developers targeting innovation and consumer appeal.
Financials and Scale
As part of Lonza Group AG:
2023 Global Revenue: CHF 6.7 billion (~USD 7.6 billion)
Employees: 17,500+ globally
Capsules & Health Ingredients Division: >200 billion capsules produced annually
Brazil Market Contribution: Strong LATAM growth driven by demand for plant-based and premium capsule technologies
Brazil is considered a high-growth market in Lonza’s global expansion strategy due to rising demand for nutraceuticals, sports nutrition, and pharmaceutical innovation.
Shipment Records
Capsules and ingredients exported across Brazil and LATAM from Lonza’s global production sites
Manufacturing sites: Primarily in Belgium, France, USA, and Japan
Lonza maintains consistent supply chains into Brazil with regulatory batch compliance and regional technical representatives.
Target Markets
Pharmaceutical contract manufacturers
Nutraceutical brands
Sports nutrition companies
Herbal medicine and dietary supplement developers
Health and wellness distributors
Formulation R&D laboratories
Capabilities
Capsule selection guidance and material compatibility testing
OEM and private-label partnerships
On-site and virtual formulation workshops
Clinical substantiation and claim support for branded ingredients
Product registration guidance with ANVISA and Mercosur authorities
Lonza supports clients from concept to commercialization using its global R&D, manufacturing, and technical infrastructure.
Certifications and Compliance
GMP Certified Manufacturing
ISO 9001 and ISO 22000
US FDA Registered
TSE/BSE Free Certification
Non-GMO, Allergen-Free, Vegan Options
Halal and Kosher Certified
ANVISA regulatory compliance and documentation support
Lonza’s capsule portfolio is also compliant with global pharmacopoeias including USP, EP, and JP.
Major Achievements
Introduced the first delayed-release vegetarian capsule (DRcaps®) in Brazil
Successfully commercialized UC-II® in multiple LATAM joint health brands
Pioneered dual-delivery (DUOCAP®) systems in sports and cognitive supplements
Supported multiple Brazilian brands transitioning to Vcaps® for clean-label claims
Developed ANVISA-compliant documentation kits for top-selling capsule systems
Customer Testimonials
“Lonza's capsule technologies give us the flexibility to offer targeted delivery systems to our customers. Their DRcaps® and Vcaps® Plus lines have helped us build premium SKUs in Brazil.”
— CEO, Nutraceutical Brand, São Paulo
“The team at Lonza Brazil helped us reformulate three of our core supplements using UC-II® and Plantcaps®. Technical support and regulatory documentation were excellent.”
— Regulatory Lead, Health & Wellness Company, Curitiba
